COVID-19 Impact on Global Adrenocortical Carcinoma Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: C22A4803F99CEN
QYResearch

Abstracts

This report focuses on the global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• Laboratoire HRA Pharma SAS
• Progenics Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• ...

Market segment by Type, the product can be split into

• Chemotherapy
• Targeted therapy

Market segment by Application, split into

• Hospital
• Research institute
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adrenocortical Carcinoma Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adrenocortical Carcinoma Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chemotherapy
  1.4.3 Targeted therapy
1.5 Market by Application
  1.5.1 Global Adrenocortical Carcinoma Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Research institute
  1.5.4 Clinic
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Adrenocortical Carcinoma Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Adrenocortical Carcinoma Drugs Industry
    1.6.1.1 Adrenocortical Carcinoma Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Adrenocortical Carcinoma Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Adrenocortical Carcinoma Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Adrenocortical Carcinoma Drugs Market Perspective (2015-2026)
2.2 Adrenocortical Carcinoma Drugs Growth Trends by Regions
  2.2.1 Adrenocortical Carcinoma Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Adrenocortical Carcinoma Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Adrenocortical Carcinoma Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Adrenocortical Carcinoma Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Adrenocortical Carcinoma Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Adrenocortical Carcinoma Drugs Players by Market Size
  3.1.1 Global Top Adrenocortical Carcinoma Drugs Players by Revenue (2015-2020)
  3.1.2 Global Adrenocortical Carcinoma Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Adrenocortical Carcinoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adrenocortical Carcinoma Drugs Market Concentration Ratio
  3.2.1 Global Adrenocortical Carcinoma Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Adrenocortical Carcinoma Drugs Revenue in 2019
3.3 Adrenocortical Carcinoma Drugs Key Players Head office and Area Served
3.4 Key Players Adrenocortical Carcinoma Drugs Product Solution and Service
3.5 Date of Enter into Adrenocortical Carcinoma Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Adrenocortical Carcinoma Drugs Historic Market Size by Type (2015-2020)
4.2 Global Adrenocortical Carcinoma Drugs Forecasted Market Size by Type (2021-2026)

5 ADRENOCORTICAL CARCINOMA DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)
5.2 Global Adrenocortical Carcinoma Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Adrenocortical Carcinoma Drugs Market Size (2015-2020)
6.2 Adrenocortical Carcinoma Drugs Key Players in North America (2019-2020)
6.3 North America Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
6.4 North America Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Adrenocortical Carcinoma Drugs Market Size (2015-2020)
7.2 Adrenocortical Carcinoma Drugs Key Players in Europe (2019-2020)
7.3 Europe Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
7.4 Europe Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Adrenocortical Carcinoma Drugs Market Size (2015-2020)
8.2 Adrenocortical Carcinoma Drugs Key Players in China (2019-2020)
8.3 China Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
8.4 China Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Adrenocortical Carcinoma Drugs Market Size (2015-2020)
9.2 Adrenocortical Carcinoma Drugs Key Players in Japan (2019-2020)
9.3 Japan Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
9.4 Japan Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Adrenocortical Carcinoma Drugs Market Size (2015-2020)
10.2 Adrenocortical Carcinoma Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Adrenocortical Carcinoma Drugs Market Size (2015-2020)
11.2 Adrenocortical Carcinoma Drugs Key Players in India (2019-2020)
11.3 India Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
11.4 India Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Adrenocortical Carcinoma Drugs Market Size (2015-2020)
12.2 Adrenocortical Carcinoma Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020)
12.4 Central & South America Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bristol-Myers Squibb Co.
  13.1.1 Bristol-Myers Squibb Co. Company Details
  13.1.2 Bristol-Myers Squibb Co. Business Overview and Its Total Revenue
  13.1.3 Bristol-Myers Squibb Co. Adrenocortical Carcinoma Drugs Introduction
  13.1.4 Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020))
  13.1.5 Bristol-Myers Squibb Co. Recent Development
13.2 Eli Lilly and Co.
  13.2.1 Eli Lilly and Co. Company Details
  13.2.2 Eli Lilly and Co. Business Overview and Its Total Revenue
  13.2.3 Eli Lilly and Co. Adrenocortical Carcinoma Drugs Introduction
  13.2.4 Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020)
  13.2.5 Eli Lilly and Co. Recent Development
13.3 Laboratoire HRA Pharma SAS
  13.3.1 Laboratoire HRA Pharma SAS Company Details
  13.3.2 Laboratoire HRA Pharma SAS Business Overview and Its Total Revenue
  13.3.3 Laboratoire HRA Pharma SAS Adrenocortical Carcinoma Drugs Introduction
  13.3.4 Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020)
  13.3.5 Laboratoire HRA Pharma SAS Recent Development
13.4 Progenics Pharmaceuticals Inc.
  13.4.1 Progenics Pharmaceuticals Inc. Company Details
  13.4.2 Progenics Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.4.3 Progenics Pharmaceuticals Inc. Adrenocortical Carcinoma Drugs Introduction
  13.4.4 Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020)
  13.4.5 Progenics Pharmaceuticals Inc. Recent Development
13.5 Teva Pharmaceutical Industries Ltd.
  13.5.1 Teva Pharmaceutical Industries Ltd. Company Details
  13.5.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  13.5.3 Teva Pharmaceutical Industries Ltd. Adrenocortical Carcinoma Drugs Introduction
  13.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020)
  13.5.5 Teva Pharmaceutical Industries Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Adrenocortical Carcinoma Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Adrenocortical Carcinoma Drugs Revenue
Table 3. Ranking of Global Top Adrenocortical Carcinoma Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Targeted therapy
Table 7. COVID-19 Impact Global Market: (Four Adrenocortical Carcinoma Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Adrenocortical Carcinoma Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Adrenocortical Carcinoma Drugs Players to Combat Covid-19 Impact
Table 12. Global Adrenocortical Carcinoma Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Adrenocortical Carcinoma Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Adrenocortical Carcinoma Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Adrenocortical Carcinoma Drugs Market Share by Regions (2015-2020)
Table 16. Global Adrenocortical Carcinoma Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Adrenocortical Carcinoma Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Adrenocortical Carcinoma Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Adrenocortical Carcinoma Drugs Players
Table 23. Global Adrenocortical Carcinoma Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Adrenocortical Carcinoma Drugs Market Share by Players (2015-2020)
Table 25. Global Top Adrenocortical Carcinoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenocortical Carcinoma Drugs as of 2019)
Table 26. Global Adrenocortical Carcinoma Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Adrenocortical Carcinoma Drugs Product Solution and Service
Table 29. Date of Enter into Adrenocortical Carcinoma Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Adrenocortical Carcinoma Drugs Market Size Share by Type (2015-2020)
Table 33. Global Adrenocortical Carcinoma Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Adrenocortical Carcinoma Drugs Market Size Share by Application (2015-2020)
Table 35. Global Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Adrenocortical Carcinoma Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 39. North America Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 41. North America Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 45. Europe Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 47. Europe Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 51. China Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 53. China Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 57. Japan Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 59. Japan Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 63. Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 69. India Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 71. India Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Adrenocortical Carcinoma Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Adrenocortical Carcinoma Drugs Market Share (2019-2020)
Table 75. Central & South America Adrenocortical Carcinoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Adrenocortical Carcinoma Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Adrenocortical Carcinoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Adrenocortical Carcinoma Drugs Market Share by Application (2015-2020)
Table 79. Bristol-Myers Squibb Co. Company Details
Table 80. Bristol-Myers Squibb Co. Business Overview
Table 81. Bristol-Myers Squibb Co. Product
Table 82. Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Co. Recent Development
Table 84. Eli Lilly and Co. Company Details
Table 85. Eli Lilly and Co. Business Overview
Table 86. Eli Lilly and Co. Product
Table 87. Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020) (Million US$)
Table 88. Eli Lilly and Co. Recent Development
Table 89. Laboratoire HRA Pharma SAS Company Details
Table 90. Laboratoire HRA Pharma SAS Business Overview
Table 91. Laboratoire HRA Pharma SAS Product
Table 92. Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020) (Million US$)
Table 93. Laboratoire HRA Pharma SAS Recent Development
Table 94. Progenics Pharmaceuticals Inc. Company Details
Table 95. Progenics Pharmaceuticals Inc. Business Overview
Table 96. Progenics Pharmaceuticals Inc. Product
Table 97. Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020) (Million US$)
Table 98. Progenics Pharmaceuticals Inc. Recent Development
Table 99. Teva Pharmaceutical Industries Ltd. Company Details
Table 100. Teva Pharmaceutical Industries Ltd. Business Overview
Table 101. Teva Pharmaceutical Industries Ltd. Product
Table 102. Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business (2015-2020) (Million US$)
Table 103. Teva Pharmaceutical Industries Ltd. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Adrenocortical Carcinoma Drugs Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted therapy Features
Figure 4. Global Adrenocortical Carcinoma Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Research institute Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Adrenocortical Carcinoma Drugs Report Years Considered
Figure 10. Global Adrenocortical Carcinoma Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Adrenocortical Carcinoma Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Adrenocortical Carcinoma Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Adrenocortical Carcinoma Drugs Market Share by Players in 2019
Figure 15. Global Top Adrenocortical Carcinoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenocortical Carcinoma Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Adrenocortical Carcinoma Drugs Revenue in 2019
Figure 17. North America Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Adrenocortical Carcinoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bristol-Myers Squibb Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bristol-Myers Squibb Co. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2015-2020)
Figure 26. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Eli Lilly and Co. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2015-2020)
Figure 28. Laboratoire HRA Pharma SAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Laboratoire HRA Pharma SAS Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2015-2020)
Figure 30. Progenics Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Progenics Pharmaceuticals Inc. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2015-2020)
Figure 32. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed